Journal
STROKE
Volume 36, Issue 12, Pages 2718-2724Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1161/01.STR.0000190020.30282.cc
Keywords
brain infarction; brain ischemia; indomethacin; inflammation; ischemia; neurogenesis; stroke
Categories
Funding
- NINDS NIH HHS [P01 NS037520, F30 NS45494-01] Funding Source: Medline
Ask authors/readers for more resources
Background and Purpose - Newborn cells may participate in repair following ischemic brain injury, but their survival and function may be influenced by inflammation. Methods - We investigated the effects of indomethacin, a nonsteroidal antiinflammatory drug, on the fate of newborn cells following transient focal ischemia. Results - Bromodeoxyuridine ( BrdU)- labeled cells, including migrating neuroblasts, were observed in the neighboring striatum and overlying cortex 1 day poststroke. The density of BrdU+ cells labeled with doublecortin, nestin, glial fibrillary acidic protein, or NG2 was increased at 14 and 28 days. Indomethacin increased BrdU+ cells of all lineages and reduced microglial/monocyte activation. Conclusion - Indomethacin enhanced the accumulation of newborn cells following stroke.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available